date,title,source
Oct-18-18,Today's Research Reports on Trending Tickers: Immunomedics and FibroGen,ACCESSWIRE
Oct-25-18,FibroGen Presents Results from Two Phase 3 Studies of Roxadustat for the Treatment of Anemia Associated with Chronic Kidney Disease Conducted in China at American Society of Nephrology Kidney Week 2018 Annual Meeting,GlobeNewswire
Oct-30-18,ASN Kidney Week 2018: Data Presented from Two Japanese Phase 3 Studies on Roxadustat in the Treatment of Anemia Associated with Chronic Kidney Disease in Patients on Dialysis,GlobeNewswire
Nov-05-18,What Kind Of Shareholder Appears On The FibroGen Incs (NASDAQ:FGEN) Shareholder Register?,Simply Wall St.
Nov-08-18,"FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-08-18,FibroGen: 3Q Earnings Snapshot,Associated Press
Nov-08-18,FibroGen Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-09-18,Edited Transcript of FGEN earnings conference call or presentation 8-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-14-18,Today's Research Reports on Trending Tickers: Amicus Therapeutics and FibroGen,ACCESSWIRE
Nov-16-18,Edited Transcript of FGEN earnings conference call or presentation 8-Nov-18 10:00pm GMT,Thomson Reuters StreetEvents
Nov-27-18,"New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Dec-06-18,"FibroGen Appoints Maykin Ho, Ph.D., to Board of Directors",GlobeNewswire
Dec-17-18,FibroGen Announces Approval of Roxadustat in China for the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis,GlobeNewswire
Dec-17-18,"How Many Insiders Sold FibroGen, Inc. (NASDAQ:FGEN) Shares?",Simply Wall St.
Dec-18-18,[$$] Big Pharma Wins Drug Approval in China Ahead of West for First Time,The Wall Street Journal
Dec-18-18,Why a kidney disease drug approval in China is just the start for this S.F. company,American City Business Journals
Dec-18-18,[$$] Big Pharma Wins Drug Approval in China Ahead of West for First Time,The Wall Street Journal
Dec-18-18,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",Benzinga
Dec-18-18,Today's Research Reports on Trending Tickers: Puma Biotechnology and FibroGen,ACCESSWIRE
Dec-18-18,"China first to approve AstraZeneca, FibroGen anaemia drug",Reuters
Dec-19-18,FibroGen Inc (FGEN): Hedge Fund Sentiment Unchanged,Insider Monkey
Dec-20-18,Can This Biotech Stock Rival Amgen In Anemia? Analyst Says Yes,Investor's Business Daily
Dec-20-18,[$$] Big Pharma Wins Drug Approval in China Ahead of West for First Time,The Wall Street Journal
Dec-20-18,AstraZeneca stock up 2.8% after announcing EU approval of COPD treatment,MarketWatch
Dec-20-18,Today's Research Reports on Trending Tickers: Aimmune Therapeutics and FibroGen,ACCESSWIRE
Dec-20-18,FibroGen Announces Positive Topline Results from Three Global Phase 3 Trials of Roxadustat for Treatment of Anemia in Patients with Chronic Kidney Disease,GlobeNewswire
Jan-17-19,Today's Research Reports on Trending Tickers: Ligand Pharmaceuticals and FibroGen,ACCESSWIRE
Jan-17-19,"Analysis: Positioning to Benefit within Motorola Solutions, FibroGen, UnitedHealth Group, Newell Brands, Vuzix, and Choice Hotels International  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Feb-06-19,"How Much is FibroGen, Inc.s (NASDAQ:FGEN) CEO Getting Paid?",Simply Wall St.
Feb-20-19,Tenet Healthcare (THC) Q4 Earnings: What's in the Offing?,Zacks
Feb-22-19,What's in Store for Teladoc's (TDOC) Q4 Earnings?,Zacks
Feb-27-19,FibroGen Reports Fourth Quarter and Full Year 2018 Financial Results,GlobeNewswire
Feb-28-19,FibroGen Inc (FGEN) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-04-19,Edited Transcript of FGEN earnings conference call or presentation 27-Feb-19 10:00pm GMT,Thomson Reuters StreetEvents
Mar-05-19,What's in the Cards for Corbus (CRBP) This Earnings Season?,Zacks
Mar-06-19,"More biotech takeover targets coming, says Jefferies top analyst",CNBC Videos
Mar-07-19,"FibroGen, Inc. (NASDAQ:FGEN): Commentary On Fundamentals",Simply Wall St.
Apr-02-19,4 Biotech Stocks With Major Catalysts in April,Motley Fool
Apr-03-19,Options Traders Expect Huge Moves in FibroGen (FGEN) Stock,Zacks
Apr-08-19,"Is FibroGen, Inc. (NASDAQ:FGEN) A Financially Strong Company?",Simply Wall St.
Apr-10-19,Akebia Expands Vadadustat Licensing Deal With Vifor Pharma,Zacks
Apr-15-19,FibroGen Receives Orphan Drug Designation from the U.S. FDA For Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy,GlobeNewswire
Apr-22-19,"Health Care Digest: Attacking a deadly infant virus, Medicaid's smoking gun and exporting genetic expertise",American City Business Journals
Apr-26-19,Heres What Hedge Funds Think About FibroGen Inc (FGEN),Insider Monkey
May-01-19,Analysts Estimate FibroGen (FGEN) to Report a Decline in Earnings: What to Look Out for,Zacks
May-01-19,"How Does Investing In FibroGen, Inc. (NASDAQ:FGEN) Impact The Volatility Of Your Portfolio?",Simply Wall St.
May-02-19,"Zoetis (ZTS) Earnings Beat Estimates in Q1, Revenues Miss",Zacks
May-06-19,FibroGen to Report First Quarter 2019 Financial Results,GlobeNewswire
May-09-19,"FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates",Zacks
May-09-19,FibroGen: 1Q Earnings Snapshot,Associated Press
May-09-19,FibroGen Reports First Quarter 2019 Financial Results,GlobeNewswire
May-09-19,FibroGen Announces Positive Topline Results from Pooled Safety Analyses of Roxadustat Global Phase 3 Program,GlobeNewswire
May-10-19,"FibroGen INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In FibroGen, Inc. To Contact The Firm",GlobeNewswire
May-10-19,Edited Transcript of FGEN earnings conference call or presentation 9-May-19 9:00pm GMT,Thomson Reuters StreetEvents
May-10-19,Here's Why FibroGen Fell as Much as 26.6% Today,Motley Fool
May-10-19,FibroGen News: Why FGEN Stock Is Plummeting Today,InvestorPlace
May-10-19,"The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma's Weak Breast Cancer Drug Sales",Benzinga
